ErbB3 targeting enhances the effects of MEK inhibitor in wild-type BRAF/NRAS melanoma

Published 2018 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
ErbB3 targeting enhances the effects of MEK inhibitor in wild-type BRAF/NRAS melanoma
Authors
Keywords
-
Journal
CANCER RESEARCH
Volume -, Issue -, Pages canres.1001.2018
Publisher
American Association for Cancer Research (AACR)
Online
2018-08-16
DOI
10.1158/0008-5472.can-18-1001

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.